Seventure Partners
Overview
Seventure Partners seeks to turn innovation into entrepreneurial ventures through the financial backing and by sharing the passion of companies they invest in. The firm actively funds companies within the two evolving fields of Digital Technologies and Life Sciences, partnering with those that have strong growth potential. Life sciences
Investment Focus
- Innovative business models
- High growth potential
- Alignment with Seventure Partners' focus areas
- Positive impact on society and sustainability
Portfolio Companies
Reach Seventure Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Seventure Partners
What sectors does Seventure Partners invest in?
Seventure Partners invests in Technology, Healthcare, Software, Agriculture, FoodTech and FinTech, and is based in Paris, Île-De-France, France. Seventure Partners is listed as a vc in the ConnectSafely investor database.
What stage does Seventure Partners invest at?
Seventure Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of $1M - $3M.
Which regions does Seventure Partners invest in?
Seventure Partners invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Seventure Partners?
Team members listed for Seventure Partners include Pierre Erwes (Blue forward fund - Partner & Co founder) and Alexandre Aslanis (Chief Compliance Officer).
What companies has Seventure Partners invested in?
Seventure Partners's portfolio includes Domain Therapeutics, Animab, Citryll, CorWave, Kayentis, PEP-Therapy, MaaT Pharma and Enterome.
How do I contact Seventure Partners?
Seventure Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
